| Methods of and compositions for treatment of upper limb spasticity |
2022-2-21 |
2022-8-25 |
|
| Methods of and compositions for treatment of upper limb spasticity |
2022-2-21 |
2022-8-25 |
|
| Methods of treatment for cervical dystonia |
2021-12-09 |
2022-3-31 |
|
| Injectable botulinum toxin formulations |
2021-11-10 |
2022-2-16 |
|
| Methods for treating cervical dystonia |
2021-10-13 |
2022-4-21 |
|
| Injectable botulinum toxin formulations and methods of use thereof having long … |
2021-10-01 |
2022-1-14 |
|
| Albumin-Free Botulinum Toxin Formulations |
2021-5-18 |
2021-10-28 |
|
| Botulinum toxin and the treatment of primary disorders of mood and affect |
2021-4-19 |
2021-10-07 |
|
| Injectable botulinum toxin methods for treating headaches |
2021-3-18 |
2023-1-25 |
|
| Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect |
2020-12-28 |
2021-8-19 |
|
| Methods and kits for topical application, removal, and inactivation of … |
2020-12-07 |
2021-6-24 |
|
| Compositions and Methods for Topical and Diagnostic and Therapeutic Transport |
2020-11-20 |
2021-3-11 |
|
| Methods and Compositions for Treating Skin Conditions Associated With Vascular … |
2020-8-03 |
2022-11-03 |
|
| Compositions and methods for topical application and transdermal delivery of … |
2020-7-17 |
2020-8-06 |
|
| Injectable formulations of botulinum toxin and methods of using them that have … |
2020-7-02 |
2020-8-10 |
|
| Antimicrobial peptide, compositions, and methods of use |
2020-6-19 |
2020-10-15 |
|
| Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin |
2019-12-02 |
2020-9-03 |
|
| Compositions and Methods for Safe Treatment of Rhinitis |
2019-2-11 |
2020-11-05 |
|
| Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect |
2019-1-14 |
2019-12-19 |
|
| Botulinum toxin formulations and methods of use thereof in plantar fascitis … |
2018-11-05 |
2020-12-17 |
|
| LOCAL APPLICATION AND SKINDEUM RELEASE OF ALLANTOTOXINS |
2018-10-30 |
2019-12-11 |
|
| Compositions and methods for topical application and transdermal delivery of … |
2018-9-24 |
2020-8-18 |
2020-8-18 |
| Transmucosal botulinum toxin compositions, kits, and methods for treating … |
2018-8-28 |
2020-7-08 |
|
| Botulinum toxin for primary mood and affection disorders using a … |
2018-7-06 |
2018-11-22 |
|
| Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease |
2018-2-26 |
2020-7-16 |
|
| BIOLOGICAL INTERFERENCE-INGREDIENT TRANSPORT SYSTEMS |
2017-11-08 |
2018-6-27 |
|
| Multi-component biological transport system |
2017-4-05 |
2017-8-31 |
|
| Method of treatment of wrinkles using topical chemodenervating agents |
2016-7-19 |
2017-6-08 |
|
| Topical application and transdermal release of allantoin |
2016-1-12 |
2017-4-05 |
|
| Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter … |
2015-12-11 |
2016-4-07 |
|
| Compositions and Methods for Topical Application and Transdermal Delivery of … |
2015-12-10 |
2016-4-28 |
|
| Use of botulinum toxin for the treatment of cerebrovascular disease, … |
2015-11-03 |
2020-12-08 |
2020-12-08 |
| Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease |
2015-7-20 |
2016-1-21 |
|
| Extended length botulinum toxin formulation for human or mammalian use |
2015-6-29 |
2018-4-24 |
2018-4-24 |
| Methods and assessment scales for measuring wrinkle severity |
2015-6-01 |
2015-11-27 |
|
| Modulation of zinc levels to improve tissue properties |
2015-1-23 |
2015-7-16 |
|
| Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect |
2014-8-21 |
2017-11-09 |
|
| High-Potency Botulinum Toxin Formulations |
2014-3-25 |
2014-10-23 |
|
| Minocycline Derivatives |
2014-3-13 |
2016-2-04 |
|
| Transport molecules using reverse sequence hiv-tat polypeptides |
2013-8-06 |
2014-1-23 |
|
| Composition and method of locally applying and percutaneously delivering … |
2013-7-17 |
2014-1-09 |
|
| Compositions and methods of topical application and transdermal delivery of … |
2013-4-11 |
2013-5-02 |
|
| Arginine heteromers for topical administration |
2013-3-20 |
2013-4-11 |
|
| Arginine heteromers for topical administration |
2013-3-20 |
2016-3-31 |
2016-3-31 |
| Compositions and methods for topical application and transdermal delivery of … |
2013-3-06 |
2013-3-28 |
|
| Device and method for topical application of therapeutics or cosmetic … |
2013-2-14 |
2013-6-14 |
|
| Arginine heteromer for use in topical administration |
2012-9-27 |
2013-2-07 |
|
| Composition and method for treatment of acne |
2012-5-23 |
2012-9-27 |
|
| Multi-component biological transport systems |
2011-11-22 |
2011-12-22 |
|
| Compositions and methods for topical application and transdermal delivery of an … |
2011-8-29 |
2012-3-15 |
|
| Compositions and methods for treating hyperpigmentation |
2009-12-28 |
2011-8-29 |
|
| Arginine heteromers for topical administration |
2008-6-30 |
2008-10-03 |
|
| Compositions and methods of topical application and transdermal delivery of … |
2008-5-15 |
2008-9-26 |
|
| Composition for transdermal delivery of botulinum toxin and use of botulinum … |
2008-5-12 |
2014-1-30 |
|
| Pharmaceutical botulinum toxin compositions |
2008-3-03 |
2011-12-01 |
|
| Treatment of chronic chalazion and hordeolum with botulinum toxin |
2008-1-22 |
2008-5-22 |
|
| Compositions and Methods of Topical Application and Transdermal Delivery of … |
2007-12-12 |
2010-1-28 |
|
| Composition for therapeutic and cosmetic botulinum toxin |
2007-2-22 |
2013-11-12 |
2013-11-12 |
| Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a … |
2006-10-11 |
2009-12-31 |
|
| Compositions and methods for topical diagnostic and therapeutic transport |
2006-9-14 |
2010-11-15 |
|
| COMPOSITIONS AND METHODS FOR TOPICAL DIAGNOSIS AND THERAPEUTIC TRANSPORT |
2006-9-07 |
2007-10-01 |
|
| Heteromeros de arginina para administracion topica |
2008-6-30 |
2008-10-03 |
|
| Composiciones y metodos de aplicacion topica y suministro transdermico de … |
2008-5-15 |
2008-9-26 |
|